Resistance of Gram-negative bacterial infections
New results from the Perseus study of real-world efficacy of cefiderocol in critically ill patients
Resistance of Gram-negative bacterial infections
New results from the Perseus study of real-world efficacy of cefiderocol in critically ill patients
The treatment of bacterial infections caused by Gram-negative germs is made increasingly difficult by the growing resistance to currently available therapies. Real-world clinical evidence contributes to making the study of the action of antibiotics against multi-resistant pathogens more effective, as it allows us to overcome the methodological difficulties in carrying out prospective randomized studies, in particular on critically ill patients in advanced age.
The treatment of bacterial infections caused by Gram-negative germs is made increasingly difficult by the growing resistance to currently available therapies. Real-world clinical evidence contributes to making the study of the action of antibiotics against multi-resistant pathogens more effective, as it allows us to overcome the methodological difficulties in carrying out prospective randomized studies, in particular on critically ill patients in advanced age.
Multiresistance of Gram-negative bacteria
it
Prof. Carlo Tascini
Prospective studies on critically ill patients: why they are difficult
it
Prof. Carlo Tascini
Critically ill patients: the Perseus retrospective study on multidrug-resistant Gram-negatives
it
Prof. Carlo Tascini
Efficacy of cefiderocol against pseudomonas
it
Prof. Carlo Tascini